BioSpace News Archive

Business

STA Pharmaceutical to Open New Transition Metal Catalysis Center in Changzhou, China

STA Pharmaceutical, a WuXi AppTec company, has announced plans to launch a new transition metal catalysis center at their integrated API process R&D and manufacturing site in Changzhou China.

October 20, 2017

·

1 min read

Genetown

Syros Announces Oral Presentation Highlighting Its Drug Discovery Research in Immuno-Oncology at American College of Surgeons Clinical Congress

Syros Pharmaceuticals announced that the Company’s drug discovery research in immuno-oncology will be highlighted in an oral presentation at the American College of Surgeons (ACS) 2017 Clinical Congress taking place October 22-26 in San Diego.

October 20, 2017

·

4 min read

Policy

Abionic Announces FDA Registration for World’s Most Rapid Allergy Test and abioSCOPE Diagnostic Testing Platform

Abionic’s rapid allergy test, IVD CAPSULE Aeroallergens, and the easy to use testing platform, abioSCOPE have been registered in the United States by FDA..

October 20, 2017

·

4 min read

Business

Corrona and the National Multiple Sclerosis Society Announce Intent to Collaborate on a Multiple Sclerosis Registry to Study the Comparative Effectiveness and Safety of Approved Therapies

Corrona and the National Multiple Sclerosis Society have announced their intent to collaborate on the launch of the MS Registry to study the comparative safety and effectiveness of approved MS therapies.

October 20, 2017

·

5 min read

Genetown

Alnylam and Collaborators to Present APOLLO Phase III Study Results at 1st European ATTR Amyloidosis Meeting for Patients and Doctors

Alnylam Pharmaceuticals, Inc., the leading RNAi therapeutics company, announced today that the results of the APOLLO Phase 3 study of patisiran in hereditary ATTR (hATTR) amyloidosis patients with polyneuropathy.

October 20, 2017

·

3 min read

Business

The Medicines Company to Announce Third-Quarter 2017 Financial Results on October 25

The Medicines Company will host a conference call on Wednesday, October 25, 2017, at 8:30 a.m., Eastern Time, to discuss its third-quarter 2017 financial results and operational developments.

October 20, 2017

·

1 min read

Drug Development

AcelRx’s DSUVIA Clinical Trial Results Selected as a Top Abstract for Oral Presentation at ASA’s Annual Meeting - ANESTHESIOLOGY 2017

AcelRx today announced its clinical data presentation on the safety and efficacy of DSUVIA(sufentanil sublingual tablet), 30 mcg classified by age group across four clinical trials at the American Society of Anesthesiologists'(ASA) ANESTHESIOLOGY 2017 Annual Meeting.

October 20, 2017

·

7 min read

Business

Easton Pharmaceuticals Announces Final Payment Completing $1.3M JV Agreement With Alliance Group

Easton has advanced its final payment, completing a total payment of $1.3 Million CDN to 1124123 Ontario Limited.

October 20, 2017

·

5 min read

Pharm Country

Monaghan Medical Corporation Receives Innovative Technology Designation from Vizient for the AEROBIKA OPEP device

Monaghan Medical Corporation announced its AEROBIKA Oscillating Positive Expiratory Pressure (OPEP) device has received a 2017 Innovative Technology designation from Vizient, Inc., the largest member-driven health care performance improvement company in the country.

October 20, 2017

·

3 min read

Concordia Takes Next Step to Realign Its Capital Structure By Commencing Proceedings Under the Canada Business Corporations Act

Concordia today announced that it has taken a further step in its previously announced efforts to realign its capital structure by commencing a court proceeding under the CBCA.

October 20, 2017

·

11 min read